Browsing by Author "Najlah, M."
Now showing items 1-3 of 3
-
Development of injectable PEGylated liposome encapsulating disulfiram for colorectal cancer treatment
Najlah M.; Suliman A.S.; Tolaymat I.; Kurusamy S.; Kannappan V.; Elhissi A.M.A.; Wang W.... more authors ... less authors ( MDPI AG , 2019 , Article)Disulfiram (DS), an anti-alcoholism medicine, shows strong anti-cancer activity in the laboratory, but the application in clinics for anti-cancer therapy has been limited by its prompt metabolism. Conventional liposomes ... -
Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells
Najlah M.; Jain M.; Wan K.-W.; Ahmed W.; Albed Alhnan M.; Phoenix D.A.; Taylor K.M.G.; Elhissi A.... more authors ... less authors ( Taylor and Francis Ltd , 2018 , Article)In this study the anticancer activity of paclitaxel-loaded nano-liposomes on glioma cell lines was investigated. Soya phosphatidylcholine:cholesterol (SPC:Chol), hydrogenated soya phosphatidylcholine:cholesterol (HSPC:Chol) ... -
Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications
Rudokas, M.; Najlah, M.; Alhnan, M.A.; Elhissi, A. ( S. Karger AG , 2016 , Conference Paper)This is a critical review on research conducted in the field of pulmonary delivery of liposomes. Issues relating to the mechanism of nebulisation and liposome composition were appraised and correlated with literature reports ...